|
sc-407345-LAC-2
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L1 Lentiviral Activation Particles [Human 2]
|
Human
|
|
|
|
sc-407345-LAC
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L1 Lentiviral Activation Particles [Human]
|
Human
|
|
|
|
sc-407091-ACT-2
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L2 CRISPR Activation Plasmid [Human 2]
|
Human
|
|
|
|
sc-407091-ACT
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L2 CRISPR Activation Plasmid [Human]
|
Human
|
|
|
|
sc-407091
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L2 CRISPR/Cas9 KO Plasmid [Human]
|
Human
|
|
|
|
sc-407091-NIC-2
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L2 Double Nickase Plasmid [Human 2]
|
Human
|
|
|
|
sc-407091-NIC
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L2 Double Nickase Plasmid [Human]
|
Human
|
|
|
|
sc-407091-HDR
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L2 HDR Plasmid [Human]
|
Human
|
|
|
|
sc-407091-LAC-2
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L2 Lentiviral Activation Particles [Human 2]
|
Human
|
|
|
|
sc-407091-LAC
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L2 Lentiviral Activation Particles [Human]
|
Human
|
|
|
|
sc-410450-ACT-2
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L3 CRISPR Activation Plasmid [Human 2]
|
Human
|
|
|
|
sc-410450-ACT
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L3 CRISPR Activation Plasmid [Human]
|
Human
|
|
|
|
sc-410450
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L3 CRISPR/Cas9 KO Plasmid [Human]
|
Human
|
|
|
|
sc-410450-NIC-2
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L3 Double Nickase Plasmid [Human 2]
|
Human
|
|
|
|
sc-410450-NIC
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L3 Double Nickase Plasmid [Human]
|
Human
|
|
|
|
sc-410450-HDR
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L3 HDR Plasmid [Human]
|
Human
|
|
|
|
sc-410450-LAC-2
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L3 Lentiviral Activation Particles [Human 2]
|
Human
|
|
|
|
sc-410450-LAC
|
Santa Cruz Biotechnology
|
TNFalpha-IP 8L3 Lentiviral Activation Particles [Human]
|
Human
|
|
|
